Sang Kyun Lim

Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma

Yufeng Shi, Sang Kyun Lim, Qiren Liang et al. · Nature · 2019 · 330 citations · Full text

Medicine, Oncology, Pharmacology +11

ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation

Laura Biddlestone-Thorpe, Elizabeth Rosenberg, Jason M. Beckta et al. · Clinical Cancer Research · 2013 · 222 citations

Medicine, Oncology, Pharmacology +16

Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells

Luca Gerosa, Christopher Chidley, Fabian Fröhlich et al. · Cell Systems · 2020 · 116 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Selective inhibition of TGF-β responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP

Qiqi Cui, Sang Kyun Lim, Bryan M. Zhao et al. · Oncogene · 2005 · 56 citations

Life Sciences, Chemical Biology, Molecular Biology +14

Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c- <i>myc</i> expression in the absence of TGF-β signaling

Sang Kyun Lim, F. Michael Hoffmann · Proceedings of the National Academy of Sciences · 2006 · 50 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16